These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7032531)

  • 1. Bacterial mutation test on plafibride.
    Richold M; Jones E
    Arzneimittelforschung; 1981; 31(10a):1838-40. PubMed ID: 7032531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic approach of plafibride in rat.
    Zapatero D; Vilageliu J; Torres A; Ribalta JM; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1800-4. PubMed ID: 7198457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypolipemic activity of plafibride.
    Bruseghini L; Vilageliu J; Bagaria A
    Arzneimittelforschung; 1981; 31(10a):1796-800. PubMed ID: 7198456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicological studies of plafibride. Part 2: Subacute and subchronic toxicity in rats and chronic toxicity in dogs.
    Zapatero J; Sanfeliu C; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1819-30. PubMed ID: 7198459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of plafibride in healthy volunteers.
    Santaniello E; Conti F; Vilageliu J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1850-2. PubMed ID: 7198464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicological studies of plafibride. Part 4: Interaction of plafibride with other drugs.
    Zapatero J; Basi N; Vilageliu J; Sanfeliu C; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1835-8. PubMed ID: 7198461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicological studies of plafibride. Part 1: Acute toxicity and its determination after several administrations of plafibride.
    Zapatero J; Sanfeliu C; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1816-9. PubMed ID: 7198458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
    Bruseghini L; Vilageliu J; Freixes J
    Arzneimittelforschung; 1981; 31(10a):1790-5. PubMed ID: 6797443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological studies of plafibride. Part 3: Study of teratogenic activity in rats and rabbits.
    Sanfeliu C; Zapatero J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1831-4. PubMed ID: 7198460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxic genetic effects of flunitrazepam].
    Staiano N; Belisario MA; Della Morte R; Farina C; Remondelli P; Muscettola G
    Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2247-53. PubMed ID: 6397214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plafibride tolerance trial in healthy volunteers.
    Dalmau J; Vicens B; Zapatero J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1845-9. PubMed ID: 7198463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of plafibride on erythrocyte deformability.
    Vilageliu J; Freixes J; Bruseghini L
    Arzneimittelforschung; 1983; 33(3):401-4. PubMed ID: 6683514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plafibride tolerance trial at increasing doses in healthy volunteers.
    Dalmau J; Vicens B; Zapatero J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1840-4. PubMed ID: 7198462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of N'-morpholinomethylurea derivatives with platelet antiaggregant activity.
    Ribalta JM; Artús JJ; Salvador L; Roma E; Vilageliu J; Freixes J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1782-6. PubMed ID: 6797442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plafibride: clinical trial of a new platelet antiaggregating agent.
    Olivella J; Vicens B
    Arzneimittelforschung; 1981; 31(10a):1856-8. PubMed ID: 7032532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of plafibride in geriatric patients.
    Demichelis Genesio MA; Bracons R; Vicens B; Zapatero J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1852-5. PubMed ID: 7198465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of plafibride, an antiplatelet and hypolipemic agent, on prostacyclin and thromboxane synthesis, 3',5'-cyclic AMP phosphodiesterase activity and serum clearance of a lipid emulsion.
    Vilageliu J; Freixes J; Giráldez A; Bermejo P; Basi N; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1805-7. PubMed ID: 6274363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
    Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the biotransformation of various antineoplastic agents using the Ames test].
    Oblapenko NG; Prikhod'ko AZ; Fonshteĭn LM; Chernov VA
    Eksp Onkol; 1988; 10(5):52-5. PubMed ID: 3061779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.